4//SEC Filing
SIEGALL CLAY B 4
Accession 0001415889-24-027601
CIK 0001472012other
Filed
Nov 24, 7:00 PM ET
Accepted
Nov 25, 8:41 AM ET
Size
6.8 KB
Accession
0001415889-24-027601
Insider Transaction Report
Form 4
Immunome Inc.IMNM
SIEGALL CLAY B
DirectorPresident and CEO
Transactions
- Purchase
Common Stock
2024-11-21$9.54/sh+66,057$630,263→ 485,693 total - Purchase
Common Stock
2024-11-22$9.78/sh+33,943$331,918→ 519,636 total
Footnotes (2)
- [F1]The weighted average purchase price for the transaction report was $9.5412, and the range of prices were between $9.41 and 9.68. Upon request be the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided.
- [F2]The weighted average purchase price for the transaction report was $9.7787, and the range of prices were between $9.41 and $9.90. Upon request be the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided.
Documents
Issuer
Immunome Inc.
CIK 0001472012
Entity typeother
Related Parties
1- filerCIK 0001167496
Filing Metadata
- Form type
- 4
- Filed
- Nov 24, 7:00 PM ET
- Accepted
- Nov 25, 8:41 AM ET
- Size
- 6.8 KB